Beijing HyperStrong Technology
688411
Yalian Machinery
001395
Merit Interactive
300766
Pansoft
300996
Sublime China Information
301299
CN Stock MarketDetailed Quotes
600557 Jiangsu Kanion Pharmaceutical
- 13.17
- +0.05+0.38%
Market Closed Jan 27 15:00 CST
7.66BMarket Cap14.07P/E (TTM)
13.29High13.12Low54.82KlotVolume13.12Open13.12Pre Close72.38MTurnover0.95%Turnover Ratio14.27P/E (Static)581.80MShares23.7252wk High1.49P/B7.62BFloat Cap11.7752wk Low14.43Limit Up578.50MShs Float33.30Historical High11.81Limit Down1.30%Amplitude-0.53Historical Low0.37Dividend TTM13.20Avg Price26.88KlotAsk2.82%Div YieldTTM100Lot Size26.30KlotBid
Jiangsu Kanion Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.06%3.11B | -11.49%2.26B | 0.48%1.36B | 11.88%4.87B | 11.86%3.5B | 21.74%2.55B | 25.39%1.35B | 19.25%4.35B | 20.97%3.13B | 18.54%2.1B |
| Operating revenue | -11.06%3.11B | -11.49%2.26B | 0.48%1.36B | 11.88%4.87B | 11.86%3.5B | 21.74%2.55B | 25.39%1.35B | 19.25%4.35B | 20.97%3.13B | 18.54%2.1B |
| Other operating revenue | ---- | 19.44%17.19M | ---- | 2.98%28.27M | ---- | -28.18%14.4M | ---- | -21.44%27.46M | ---- | 1.96%20.04M |
| Total operating cost | -10.71%2.77B | -10.61%2B | -0.30%1.19B | 10.61%4.36B | 10.50%3.1B | 20.39%2.23B | 25.15%1.19B | 18.05%3.94B | 20.38%2.81B | 18.13%1.85B |
| Operating cost | -12.78%802.16M | -10.06%575.23M | 2.48%345.11M | 3.17%1.25B | 0.48%919.75M | 7.31%639.57M | 9.42%336.77M | 18.44%1.21B | 20.89%915.38M | 15.93%596.02M |
| Operating tax surcharges | -9.77%49.26M | -10.49%35.29M | 13.64%21.55M | 2.20%74.78M | 2.80%54.59M | 7.56%39.43M | 4.83%18.96M | 20.36%73.18M | 22.13%53.11M | 22.64%36.66M |
| Operating expense | -20.62%1.18B | -21.52%854.43M | -14.41%508.86M | 3.70%1.94B | 15.46%1.48B | 26.32%1.09B | 33.93%594.55M | 17.99%1.87B | 19.64%1.28B | 18.72%861.83M |
| Administration expense | 95.58%292.47M | 91.07%210.09M | 111.89%116.51M | 83.04%347.04M | 22.52%149.54M | 29.09%109.95M | 48.60%54.99M | 16.84%189.6M | 7.67%122.06M | 8.97%85.18M |
| Financial expense | -20.56%-18.44M | -128.23%-17.97M | -179.01%-9.14M | -160.96%-23.06M | -191.97%-15.3M | -261.57%-7.87M | -1,217.02%-3.28M | -207.70%-8.84M | -171.95%-5.24M | -140.14%-2.18M |
| -Interest expense (Financial expense) | ---- | ---- | ---- | ---- | ---- | -97.65%32.78K | ---- | -82.84%1.91M | -83.83%1.41M | -76.97%1.4M |
| -Interest Income (Financial expense) | -14.72%-18.81M | -118.89%-18.27M | -168.99%-9.33M | -119.37%-24.45M | -122.26%-16.39M | -94.93%-8.35M | -126.37%-3.47M | -211.16%-11.15M | -290.51%-7.38M | -335.70%-4.28M |
| Research and development | -8.48%466.74M | -6.67%339.2M | 8.24%204.12M | 27.40%771.69M | 16.67%510.01M | 31.02%363.45M | 30.78%188.58M | 21.29%605.73M | 29.78%437.12M | 28.01%277.4M |
| Credit Impairment Loss | 144.45%490.39K | 74.99%-467.89K | -109.94%-690.85K | 94.34%-120.01K | -3.06%-1.1M | -595.56%-1.87M | 2,294.65%6.95M | -472.21%-2.12M | -452.56%-1.07M | 153.05%377.55K |
| Asset Impairment Loss | ---- | ---- | ---- | -631.95%-2.77M | ---- | ---- | ---- | -64.55%521K | ---- | ---- |
| Other net revenue | 55.91%82.42M | 120.11%48.99M | -7.39%10.59M | 22.79%55.9M | 111.34%52.86M | 49.94%22.26M | 45.42%11.43M | 10.53%45.52M | 58.26%25.01M | 46.05%14.84M |
| Invest income | 55.32%10.26M | 556.06%6.11M | 1,246.80%6.03M | 252.36%14.79M | 98.50%6.61M | -63.33%932.07K | -60.25%447.98K | 3.51%4.2M | 34.33%3.33M | 37.03%2.54M |
| -Including: Investment income associates | -73.75%5.42K | -73.75%5.42K | ---- | -49.42%20.9K | -1.90%20.66K | -1.90%20.66K | ---- | 109.86%41.32K | -5.00%21.06K | -5.00%21.06K |
| Asset deal income | 2,537.79%703.69K | 2,537.79%703.69K | ---55.32K | -45.12%757.74K | -102.44%-28.87K | -12,033.04%-28.87K | ---- | 42.98%1.38M | -16.35%1.18M | -100.41%-237.91 |
| Other revenue | 49.74%70.96M | 83.60%42.64M | 31.36%5.3M | 4.08%43.24M | 119.68%47.39M | 94.76%23.23M | -37.38%4.04M | 21.74%41.54M | 78.20%21.57M | 33.05%11.93M |
| Operating profit | -5.54%422.3M | -8.68%312.51M | 5.33%182.59M | 23.96%563.79M | 30.17%447.06M | 33.11%342.23M | 28.22%173.36M | 29.58%454.81M | 28.38%343.45M | 23.00%257.11M |
| Add:Non operating Income | 738.72%11.78M | 900.43%10.81M | 353.86%954.06K | 84.80%6.16M | -55.45%1.4M | -61.85%1.08M | 51.13%210.21K | 432.47%3.33M | 561.12%3.15M | 407.81%2.83M |
| Less:Non operating expense | -49.21%6.82M | -24.00%6.51M | 306.21%5.95M | 52.64%18.96M | 33.73%13.42M | -2.11%8.56M | -64.06%1.46M | -46.77%12.42M | -43.58%10.04M | -49.29%8.75M |
| Total profit | -1.79%427.26M | -5.36%316.81M | 3.19%177.6M | 23.62%550.98M | 29.26%435.04M | 33.26%334.75M | 31.11%172.11M | 35.78%445.72M | 34.51%336.56M | 30.60%251.2M |
| Less:Income tax cost | -15.96%63.28M | -12.23%45.52M | 4.47%28.03M | 3.52%3.93M | 43.17%75.29M | 30.19%51.86M | 28.43%26.83M | -2.99%3.8M | 32.13%52.59M | 29.76%39.83M |
| Net profit | 1.18%363.98M | -4.10%271.3M | 2.96%149.57M | 23.79%547.05M | 26.69%359.75M | 33.84%282.89M | 31.61%145.27M | 36.25%441.92M | 34.96%283.97M | 30.77%211.36M |
| Net profit from continuing operation | 1.18%363.98M | -4.10%271.3M | 2.96%149.57M | 23.79%547.05M | 26.69%359.75M | 33.84%282.89M | 31.61%145.27M | 36.25%441.92M | 34.96%283.97M | 30.77%211.36M |
| Less:Minority Profit | -33.14%6.84M | -18.08%5.87M | -60.28%1.52M | 38.47%10.32M | 287.96%10.23M | 2,842.63%7.17M | 875.32%3.83M | 95.72%7.45M | -19.81%2.64M | -88.52%243.6K |
| Net profit of parent company owners | 2.18%357.14M | -3.73%265.42M | 4.67%148.04M | 23.54%536.73M | 24.24%349.53M | 30.60%275.72M | 28.60%141.44M | 35.54%434.47M | 35.83%281.34M | 32.35%211.12M |
| Earning per share | ||||||||||
| Basic earning per share | 1.64%0.62 | -2.13%0.46 | 4.00%0.26 | 24.00%0.93 | 24.49%0.61 | 27.03%0.47 | 31.58%0.25 | 33.93%0.75 | 36.11%0.49 | 32.14%0.37 |
| Diluted earning per share | 3.33%0.62 | -2.13%0.46 | 4.17%0.25 | 24.00%0.93 | 22.45%0.6 | 27.03%0.47 | 26.32%0.24 | 33.93%0.75 | 36.11%0.49 | 32.14%0.37 |
| Other composite income | ||||||||||
| Total composite income | 1.18%363.98M | -4.10%271.3M | 2.96%149.57M | 23.79%547.05M | 26.69%359.75M | 33.84%282.89M | 31.61%145.27M | 36.25%441.92M | 34.96%283.97M | 30.77%211.36M |
| Total composite income of parent company owners | 2.18%357.14M | -3.73%265.42M | 4.67%148.04M | 23.54%536.73M | 24.24%349.53M | 30.60%275.72M | 28.60%141.44M | 35.54%434.47M | 35.83%281.34M | 32.35%211.12M |
| Total composite income of minority owners | -33.14%6.84M | -18.08%5.87M | -60.28%1.52M | 38.47%10.32M | 287.96%10.23M | 2,842.63%7.17M | 875.32%3.83M | 95.72%7.45M | -19.81%2.64M | -88.52%243.6K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
